Australian researchers have used a new CRISPR activation tool to identify a previously unknown gene involved in resistance to a widely used blood cancer drug, as well as several genes linked to accelerated lymphoma growth. Researchers from the Olivia Newton-John Cancer Research Institute (ONJCRI), WEHI and Genentech used the clustered regularly interspaced short palindromic repeats [...]